Neurocrine Biosciences Inc

Ownership Transactions Reported by 21 Insiders

Symbol
NBIX on Nasdaq
Location
6027 Edgewood Bend Court, San Diego, California

Insiders trading volume in the past year

Neurocrine Biosciences Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kevin Charles Gorman Chief Executive Officer, Director $71.4 M -$24.8 M -25.8% Feb 13, 2024
Kyle Gano Chief Business Development Off $19.2 M -$10.8 M -36.1% Feb 13, 2024
Gary A. Lyons Director $17.1 M -$4.71 M -21.6% May 22, 2024
Dimitri E. Grigoriadis Chief Research Officer $15.6 M Jan 31, 2022
Darin Lippoldt Chief Legal Officer $10.6 M -$5.94 M -36% Feb 13, 2024
William H. Rastetter Director $7.64 M -$1.45 M -16% May 22, 2024
Eiry Roberts Chief Medical Officer $6.87 M -$14.3 M -67.5% Feb 13, 2024
Eric Benevich Chief Commercial Officer $6.48 M -$24 M -78.7% Apr 15, 2024
Malcolm Lloyd-Smith Chief Integration Officer $5.92 M Feb 6, 2023
Matt Abernethy Chief Financial Officer $5.91 M -$5.04 M -46% May 14, 2024
Richard F. Pops Director $4.89 M -$5.79 M -54.2% May 22, 2024
Julie Cooke Chief Human Resources Officer $4.29 M -$5.51 M -56.2% Jul 1, 2024
Stephen Sherwin Director $3.94 M -$5.34 M -57.5% May 29, 2024
Jude Onyia Chief Scientific Officer $3.18 M -$816 K -20.4% Feb 13, 2024
Ingrid Delaet Chief Regulatory Officer $2.1 M -$3.05 M -59.2% Jul 1, 2024
David W. Boyer Chief Corp. Affairs Officer $1.47 M -$1.41 M -48.9% Feb 13, 2024
Morrow George J Director $1 M -$5.58 M -84.8% May 22, 2024
Johanna Mercier Director $718 K May 22, 2024
Shalini Sharp Director $564 K -$157 K -21.8% May 22, 2024
Leslie Norwalk Director $564 K -$1.24 M -68.8% May 22, 2024
Christine A. Poon Director $423 K May 22, 2024

Recent Insider Transactions by Companies or Individuals for Neurocrine Biosciences Inc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership